Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.

Diana Hausman
Executive Advisor
Anthony Polverino
EVP, Early Development & Chief Scientific Officer
Neil Klompas
EVP, Business Operations & CFO
Neil Josephson
Chief Medical Officer
Kathryn O’Driscoll
Chief People Officer
James Priour
Chief Commercial Officer
Mark Hollywood
SVP, Technical & Manufacturing Operations
Bruce Hart
SVP, Regulatory Affairs
David Poon
VP, Business Development & Alliance Management
Jennifer Kaufman-Shaw
VP, Intellectual Property
Steven Xanthoudakis
VP, Global Search & External Scientific Strategy
Surjit Dixit
VP, Technology

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.